1-6 of 6
Jessie-F. Fecteau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21 WAF1/Cip1 -dependent mechanism independent of functional p53

Jessie-F. Fecteau, Laura G. Corral, Emanuela M. Ghia, Svetlana Gaidarova, Diahnn Futalan, Ila Sri Bharati, Brian Cathers, Maria Schwaederlé, Bing Cui, Antonia Lopez-Girona, Davorka Messmer, Thomas J. Kipps
Journal: Blood
Blood (2014) 124 (10): 1637–1644.
https://doi.org/10.1182/blood-2014-03-559591
Published: 2014
Includes: Supplemental data
Journal Articles

MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia

Bing Cui, Liguang Chen, Suping Zhang, Marek Mraz, Jessie-F. Fecteau, Jian Yu, Emanuela M. Ghia, Ling Zhang, Lei Bao, Laura Z. Rassenti, Karen Messer, George A. Calin, Carlo M. Croce, Thomas J. Kipps
Journal: Blood
Blood (2014) 124 (4): 546–554.
https://doi.org/10.1182/blood-2014-03-559690
Published: 2014
Includes: Supplemental data
Journal Articles

Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia

Brief Report
Jessie-F. Fecteau, Davorka Messmer, Suping Zhang, Bing Cui, Liguang Chen, Thomas J. Kipps
Journal: Blood
Blood (2013) 121 (6): 971–974.
https://doi.org/10.1182/blood-2012-08-447813
Published: 2013
Includes: Supplemental data
Journal Articles

Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib

Davorka Messmer, Jessie-F. Fecteau, Morgan O'Hayre, Ila S. Bharati, Tracy M. Handel, Thomas J. Kipps
Journal: Blood
Blood (2011) 117 (3): 882–889.
https://doi.org/10.1182/blood-2010-04-282400
Published: 2011
Includes: Supplemental data
Journal Articles

CXCL12 Enhances Survival of Chronic Lymphocytic Leukemia Cells Via a RAF-Dependent Pathway That Can Be Inhibited by Sorafenib

Davorka Messmer, PhD, Jessie-F Fecteau, PhD, Morgan O'Hayre, BS, Tracy Handel, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2445.
https://doi.org/10.1182/blood.V116.21.2445.2445
Published: 2010
Journal Articles

The Kinase Inhibitor Sorafenib Can Disrupt the Survival Support Provided by the Microenvironment and Induce Apoptosis of Chronic Lymphocytic Leukemia Cells

Jessie-F Fecteau, PhD, Ila Bharati, BS, Morgan O'Hayre, BS, Tracy Handel, Thomas J. Kipps, MD, PhD, Davorka Messmer, PhD
Journal: Blood
Blood (2010) 116 (21): 47.
https://doi.org/10.1182/blood.V116.21.47.47
Published: 2010